DNA is strictly compartmentalized within the nucleus to prevent autoimmunity 1 ; despite this, cyclic GMP-AMP synthase (cGAS), a cytosolic sensor of double-stranded DNA, is activated in autoinflammatory disorders and by DNA damage 2-6 . Precisely how cellular DNA gains access to the cytoplasm remains to be determined. Here, we report that cGAS localizes to micronuclei arising from genome instability in a mouse model of monogenic autoinflammation, after exogenous DNA damage and spontaneously in human cancer cells. Such micronuclei occur after mis-segregation of DNA during cell division and consist of chromatin surrounded by its own nuclear membrane. Breakdown of the micronuclear envelope, a process associated with chromothripsis 7 , leads to rapid accumulation of cGAS, providing a mechanism by which self-DNA becomes exposed to the cytosol. cGAS is activated by chromatin, and consistent with a mitotic origin, micronuclei formation and the proinflammatory response following DNA damage are cellcycle dependent. By combining live-cell laser microdissection with single cell transcriptomics, we establish that interferon-stimulated gene expression is induced in micronucleated cells. We therefore conclude that micronuclei represent an important source of immunostimulatory DNA. As micronuclei formed from lagging chromosomes also activate this pathway, recognition of micronuclei by cGAS may act as a cell-intrinsic immune surveillance mechanism that detects a range of neoplasia-inducing processes.
instability ( Fig. 1c , Supplementary Video 1, Extended Data Fig. 1a, b and Supplementary Information). Increased micronuclei formation was also observed in Rnaseh2b A174T/A174T mice (P = 0.003; Extended Data Fig. 1c, d) , a model for the autoinflammatory disorder Aicardi-Goutières syndrome, confirming that micronuclei arise as a result of RNase H2 deficiency both in vitro and in vivo, irrespective of p53 status. As the interferon-stimulated gene (ISG) upregulation and proinflammatory response in both Rnaseh2b −/− MEFs and Rnaseh2b A174T/A174T mice is cGAS-and STING-dependent 5 , accumulation of micronuclear DNA correlated with activation of the cGAS and STING pathway. Furthermore, investigation of the subcellular localization of cGAS in Rnaseh2b −/− MEFs stably expressing GFP-cGAS established that cGAS was strongly enriched in micronuclei ( Fig. 1d ; 83.3 ± 1.4% of micronuclei were GFP-cGAS-positive), whereas GFP alone showed no such localization (Extended Data Fig. 1e , f), consistent with cGAS binding to micronuclear DNA.
To determine whether localization of cGAS to micronuclei was a general phenomenon, exogenous DNA damage was induced in GFP-cGAS-expressing MEFs. After 1 Gy irradiation, we observed frequent localization of cGAS to micronuclei (Fig. 1e ), along with a cGASdependent proinflammatory response. Increased secretion of CCL5 (a robust indicator of cGAS-dependent ISG responses in MEFs 5 ) correlated with increased frequency of micronuclei in both Trp53 +/+ and Trp53 −/− MEFs (Fig. 1f-h ). Furthermore, consistent with an increased tendency to form micronuclei in Trp53 −/− cells, following irradiation both micronucleus formation (P = 0.0078) and CCL5 production (P = 0.020) were significantly enhanced compared with Trp53 +/+ cells. ISG transcripts were also induced (Extended Data Fig. 1g ) at levels comparable to those found in previous studies of genotoxic damage 2, 4 .
In human U2OS osteosarcoma epithelial cells, endogenous cGAS was detected by immunofluorescence in spontaneously formed micronuclei (Extended Data Fig. 1h-j) . Strong micronuclear enrichment of cGAS contrasted with weak diffuse cytoplasmic localization in cells without micronuclei, consistent with endogenous relocalization of cGAS to micronuclei. We therefore conclude that cGAS frequently localizes to micronuclei, irrespective of the source of DNA damage initiating their formation. However, given that a nuclear envelope normally encloses micronuclei, it was not clear how cGAS gains access to these structures.
Micronuclear DNA is particularly susceptible to DNA damage, leading to chromothripsis 7, 17 . This occurs as a consequence of irreversible nuclear envelope collapse, which arises frequently in micronuclei due to defective nuclear lamina organization 18 . Given that this leads to partial loss of compartmentalization, we postulated that membrane rupture would also result in relocalization of cGAS to micronuclei, to induce a cGAMP-driven proinflammatory response ( Fig. 2a ). Consistent with this, we observed that micronuclei positive for γ H2AX, Letter reSeArCH a marker of DNA damage, contained cGAS more often than those without γ H2AX staining (P = 0.0169, Rnaseh2b −/− MEFs; P = 0.0005, U2OS cells; Extended Data Fig. 2a-c) . Moreover, co-staining of U2OS cells for cGAS and the nuclear protein retinoblastoma (Rb), a marker for micronuclei with intact nuclear envelopes 18 , demonstrated that the majority of cGAS-positive micronuclei had ruptured nuclear envelopes ( Fig. 2b, c) . Loss of an mCherry-tagged nuclear localization signal (mCherry-NLS) was also strongly associated with localization of cGAS to micronuclei (Extended Data Fig. 3a, b ), further supporting a link between membrane integrity failure and cGAS relocalization. To establish a direct temporal relationship between nuclear envelope rupture and cGAS relocalization, we performed live imaging in U2OS cells expressing mCherry-NLS and GFP-cGAS ( Fig. 2d , Extended Data Fig. 3c ). cGAS entered the micronuclei rapidly after loss of membrane Relative uorescence intensity integrity, as measured by loss of micronuclear mCherry-NLS ( Fig. 2e , Supplementary Video 2). We therefore conclude that nuclear envelope rupture results in exposure of DNA to the cytoplasmic compartment, leading to relocalization of cGAS to micronuclear chromatin.
Activation of cGAS requires dimerization, with each cGAS monomer binding a dsDNA molecule 19 . Combined, these requirements might therefore preclude activation of cGAS that is bound to chromatin. In addition, a published model suggests that there would be steric clashes between bound DNA molecules and predicts that cGAS activation will therefore occur near the ends of dsDNA 20 . However, we reasoned that the flexible nature of DNA could permit cGAS dimerization on continuous DNA and chromatin, given the accessibility of linker DNA between nucleosomes. To test whether cGAS can be activated by DNA that does not contain free ends, we measured production of cGAMP by recombinant cGAS in the presence of plasmid DNA using a chromatography-based assay and found that cGAMP production was similar in the presence of either circular DNA or fragmented plasmid DNA ( Fig. 3a , b, Extended Data Fig. 4a , b), establishing that DNA ends are not required for activation of cGAS. Furthermore, supercoiled plasmid DNA induced strong cGASdependent CCL5 production in MEFs (Extended Data Fig. 4c ). We then prepared synthetic chromatin and found that cGAS can also bind to DNA in the presence of nucleosomes (Extended Data Fig. 5a , b) and that this leads to substantial cGAMP production ( Fig. 3c , Extended Data Fig. 5c ). Chromatin isolated from cells also activated recombinant cGAS (Extended Data Fig. 5d -g). We therefore conclude that cGAS can bind to and be activated by chromatin.
Small DNA fragments detected by antibodies against dsDNA have been proposed to leak from sites of DNA damage through the interphase nuclear envelope into the cytoplasm and to activate the cGAS-STING pathway 2, 21 . In contrast, as micronuclei are generated at mitosis, a prediction of our model is that the immune response will be cell-cycle dependent. To test this prediction, we induced DNA damage in MEFs arrested in G0 by serum starvation. Such cell-cycle-arrested MEFs still displayed functional cGAS signalling, producing similar amounts of cytokine in response to transfected exogenous DNA compared with actively cycling cells (Extended Data Fig. 6a, b ). However, cell-cycle-arrested MEFs did not form micronuclei, nor did they exhibit innate immune activation after exposure to equivalent levels of ionizing radiation, despite undergoing equal levels of DNA damage ( Fig. 4a-d , Extended Data Fig. 6d, e ). Therefore, DNA damage is not sufficient by itself to generate innate immune activation in response to ionizing radiation; with the dependence on cell-cycle progression consistent with mis-segregated DNA at mitosis being the origin of cGAS activation. Quantification of the levels of micronuclear DNA (Extended Data Fig. 7) indicates that it would be sufficient to generate a relevant cytokine response, also supporting micronuclei as an important source of cell-intrinsic immunostimulatory DNA.
We also investigated whether micronuclei initiated by a DNA damage-independent mechanism resulted in similar cGAS relocalization and an associated proinflammatory response. Micronuclei containing whole chromosomes were generated through pharmacological induction of lagging chromosomes by nocodazole treatment 7, 18 (Extended Data Fig. 8a, b ). This resulted in a substantially increased frequency of micronuclei in both MEFs and U2OS cells (Extended Data Fig. 8c, d ). The number of cGAS-positive micronucleated cells b, CCL5 production is significantly increased after irradiation in cycling (asynchronous) cells, but not in cells arrested in G0 after serum starvation. c, The percentage of cells containing micronuclei is increased after irradiation in cycling but not G0-arrested cells. Mean ± s.e.m., n = 3 independent experiments. d, Cycling and G0-arrested cells exhibit the same level of DNA damage, as measured by formation of γ H2AX foci. Mean ± s.d., n = 2 independent experiments, ≥100 cells analysed per condition per experiment. Only 1 Gy quantified, as γ H2AX foci overlapped substantially at 5 Gy; see Extended Data Fig. 6 ). * * P < 0.01, * * * P < 0.001, two-tailed t-test; NS, not significant. Letter reSeArCH also increased significantly (P = 0.0083; Extended Data Fig. 8e ), leading us to conclude that nocodazole-induced micronuclei could also be detected by endogenous cGAS. Induction of micronuclei by nocodazole also induced a proinflammatory response with significantly elevated CCL5 cytokine production in MEFs (P = 0.0008; Extended Data Fig. 8f ). This response, but no increase in DNA damage, was detected from 16 h after nocodazole treatment, consistent with a post-mitotic origin (Extended Data Fig. 8h , j). We therefore conclude that micronuclei arising from mis-segregated chromosomes, as well as genome instability, can induce cGAS signalling.
To confirm a direct relationship between micronuclei and cGAS pathway activation, we assessed at the single-cell level whether the induction of ISGs was specific to micronucleated cells. Forty-eight hours after irradiation (1 Gy), we identified individual micronucleated cells (MN+ ) and control cells with normal nuclear morphology (MN− ) microscopically (Extended Data Fig. 9 ) and isolated them using laser capture microdissection for subsequent single-cell mRNA sequencing ( Fig. 5a ). To avoid confounding biases, all cells were collected from the same culture dish and processed in parallel, with library preparation performed in a single 96-well plate with MN+ and MN− cells interdigitated, and sequencing datasets down-sampled to the same number of reads after mapping. For the thirty-five RNA sequencing libraries that passed quality control (Extended Data Fig. 9a ), we first examined a high-confidence list of 11 ISGs that had been previously shown to be induced by endogenous genome instability in MEFs 5 . Six of the ISGs were represented in the RNA sequencing data, and strikingly we detected transcripts for five of these (Ccl5, Isg15, Ifi27l2a, Samd9l and Cxcl10) specifically in micronucleated cells (P = 0.047, Fisher's exact test, Fig. 5b ). Examination of pooled cells down-sampled to identical numbers of sequence reads aligned to these individual genes confirmed differential expression between MN+ and MN− cells ( Fig. 5c ).
We next assessed the MN+ -specific upregulation of a large set of independently defined type I IFN-induced genes (n = 336 ISGs) on a transcriptome-wide basis. We performed a gene set enrichment analysis (GSEA) against genes ranked by z-scores for differential expression (MN+ versus MN− ) calculated by the Single Cell Differential Expression (SCDE) analysis package. GSEA confirmed that expression of these ISGs was significantly enriched in the pool of micronucleated cells over control cells ( Fig. 5d ; normalized enrichment score 1.52, P = 2.04 × 10 −4 ). These single-cell analyses were therefore consistent with micronucleated cells being the source of DNA damage-induced ISGs (Fig. 5e ). In conclusion, while the formal possibility remains that other dsDNA fragments in cells with micronuclei also activate cGAS, this and our other experimental findings strongly implicate micronuclei as a substantial source of cell-intrinsic immunostimulatory DNA.
Micronuclear membrane breakdown provides a mechanism by which dsDNA is exposed to the cytoplasmic sensor cGAS, with spontaneous rupture being frequent and generally irreversible 18 . As chromatin activates cGAS, physiological ruptures in the primary nuclear membrane when cells migrate through tight interstitial spaces ISG. Control genes shaded in red according to read count relative to the maximum observed for each gene. c, Alignment of pooled sequence reads to Isg15 and Hmg3b (Ensembl mouse reference genome version GRCm38. p5). d, Transcriptome-wide analysis (GSEA) demonstrates that a set of 336 ISGs is significantly enriched (P = 2.04 × 10 −4 ) in transcriptomes of micronucleated cells. e, Interpretation of single-cell data: after induction of DNA damage by irradiation, ISG upregulation occurs preferentially in micronucleated cells rather than those with normal nuclear morphology exposed to identical experimental conditions. may also cause transient cGAS activation 22, 23 . Notably, mitotic chromosomes are temporarily exposed to the cytosol, prompting the important unanswered question of how cGAS-STING pathway activation is prevented during cell division. Although cGAS can localize to nuclear DNA during mitosis (Extended Data Fig. 10a, b) , the transient nature of mitosis, hypercompaction of DNA and the peri-chromosomal layer of proteins may mitigate against cGAS binding and activation. In addition, post-translational regulation of cGAS or downstream pathway components in conjunction with transcriptional silencing of mitotic chromosomes could also prevent ISG induction.
Conversely, nuclear membrane breakdown in disease states 24 may be pathologically relevant. Additionally, other aberrant structures generated during cell division may lead to cytosolic DNA exposure. For instance, we infrequently observed cGAS on interphase chromatin bridges in Rnaseh2b −/− cells and in U2OS cells (Extended Data Fig. 10c, d) , so persistent chromatin bridges, such as those arising after telomere crisis 25 , could also activate cGAS. Furthermore, while we observed enhanced ISG induction in micronucleated cells, free dsDNA fragments, perhaps released at mitosis, might also activate cGAS in specific contexts. Therefore, while micronuclei provide a substantial source of immunostimulatory DNA, in other pathological contexts additional mechanisms that impair nuclear compartment integrity may play a role.
Micronuclei frequently form in cancer cells 26 , and chromosome and genome instability are key drivers of neoplasia 27, 28 . Hence, our work predicts that cGAS will often become activated by this route during neoplastic transformation, leading to cGAS-and STING-dependent tumour-suppressive immune responses 29, 30 . Consequently, there may be selection pressures during cancer evolution to inactivate cGAS-STING signalling, providing an additional explanation for its frequent inactivation in tumours 31 , alongside oncogene-mediated silencing associated with virally induced neoplasia 32 . In conclusion, sensing of ruptured micronuclei by cGAS represents a cell-intrinsic surveillance mechanism that links genome instability to innate immune responses, of relevance to both cancer and autoinflammation.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Letter reSeArCH MethOdS Mice. The following lines (intercrossed where necessary) were used to provide cells and cell lines for this study: C57BL/6J Rnaseh2b tm1d/+ (referred to as Rnaseh2b +/− ) 5 , C57BL/6J Rnaseh2b tm2-hgu-A174T (referred to as Rnaseh2b A174T/A174T ) 5 , Trp53 tm1tyj /J (referred to as Trp53 +/− ) 33 and C57BL/6NTac-Mb21d1 tm1a(EUCOMM)Hmgu /IcsOrl (referred to as Mb21d1 −/− or cGAS −/− ) 34 . The latter was obtained from the Institute Clinique de la Souris via the European Mouse Mutant Archive. All mouse work was performed in accordance with UK Home Office regulations under a UK Home Office project licence (PPL 60/4424). Cells and cell culture. C57BL/6J Rnaseh2b −/− Trp53 −/− and Rnaseh2b +/+ Trp53 −/− MEFs were generated from individual embryonic day 10.5 (E10.5) embryos as previously described 5 . C57BL/6NTac Mb21d1 −/− MEFs and C57BL/6J (Trp53 +/+ ) MEFs were generated from E13.5 embryos. MEFs were maintained in DMEM supplemented with 10% fetal bovine serum (FBS), 50 U ml −1 penicillin, 50 μ g ml −1 streptomycin and 0.1 mM β -mercaptoethanol at 37 °C in 5% CO 2 and 3% O 2 .
U2OS cells were purchased from the European Collection of Authenticated Cell Cultures (ECACC, Cat no. 92022711) and maintained in McCoy's 5A medium with l-glutamine (Gibco) supplemented with 10% FBS, 50 U ml −1 penicillin and 50 μ g ml −1 streptomycin at 37 °C in 5% CO 2 . All cells were mycoplasma-free, with regular checks performed using the Lonza-Mycoalert Mycoplasma Detection Kit. Generation of stable cell lines. Rnaseh2b +/+ Trp53 −/− and Rnaseh2b −/− Trp53 −/− MEFs and U2OS cells stably expressing GFP or GFP-cGAS were generated as follows. GFP-cGAS (the result of cloning the mouse or human cGAS coding sequence into a Gateway-compatible version of pEGFP-C1) and GFP were amplified by PCR and cloned into pMSCV. The resulting pMSCV vectors were transfected into Phoenix packaging cells to generate ecotropic or amphotropic viral particles 35 , and retroviral supernatant was used to infect the relevant cell lines in the presence of 4 μ g ml −1 polybrene. Cells were selected for stable integration using 2 μ g ml −1 puromycin, and maintained as a heterogeneous pool of stably expressing cells. Stable U2OS GFP-cGAS cells were transfected with pmCherry-NLS (a gift from M. Offterdinger, Addgene plasmid 39319) 36 using lipofectamine 3000 and selected with 500 μ g ml −1 neomycin (G418, Sigma). Immunofluorescence. Cells were grown on glass coverslips and fixed in 4% paraformaldehyde (PFA) in PBS for 20 min at room temperature. Cells were permeabilized in 0.5% Triton X-100 for 5 min before blocking for 30 min with 1% BSA in PBS. Coverslips were then incubated with primary antibody for 1 h, followed by incubation with a secondary antibody for 45 min. Primary and secondary antibodies were diluted in blocking buffer and all incubations were performed at room temperature. Coverslips were mounted using Vectashield Antifade Mounting Medium with DAPI (Vector Laboratories) and imaged using a Photometrics Coolsnap HQ2 CCD camera and a Zeiss Axioplan II fluorescence microscope with plan-neofluor objectives and images captured with iVision software (BioVision Technologies). All scoring was performed under blinded conditions.
The following antibodies were used for immunofluorescence: cGAS (D1D3G, Cell Signalling, 1:200), phospho-histone H2A.X (Ser139) (2577, Cell Signalling, 1:800), Lamin B1 (ab16048, Abcam, 1:1,000) and Retinoblastoma (554136, BD Biosciences, 1:200). Secondary antibodies, anti-mouse-Alexa488 (A11029), anti-rabbit-Alexa 488 (A11008) and anti-rabbit-Alexa568 (A11036) (all Invitrogen), were used at 1:500 or 1:1,000 dilution. Determination of micronucleus frequency. After fixation and DAPI staining, the percentage of cells with micronuclei was determined by microscopy under blinded conditions. Micronuclei were defined as discrete DNA aggregates separate from the primary nucleus in cells where interphase primary nuclear morphology was normal. Cells with an apoptotic appearance were excluded. Erythrocyte micronucleus assay. The presence of micronuclei in erythrocytes was quantified using previously described methods 37 . 50 μ l of blood from female Rnaseh2b A174T/A174T mice and age-matched (7-8 months old) and sex-matched control C57BL/6J mice was collected and expelled into 250 μ l heparin solution (500 USP units per ml PBS) on ice. 180 μ l of this suspension was expelled into 2 ml of pre-cooled (− 80 °C) methanol and aggregates removed by robust tube tapping. The cell suspension was incubated at − 80 °C for at least 24 h before staining for flow cytometry.
To stain the cells, 12 ml ice-cold saline solution (0.9% w/v NaCl, 5.3 mM NaHCO 3 , pH 7.3) was added to the cell suspension and the tube was inverted to mix and placed on ice. Cells were centrifuged at 600g for 5 min at 4 °C, supernatant removed and cells resuspended by pipetting. 10 μ l of cells per sample was stained with 90 μ l of staining solution containing 79 μ l saline solution, 10 μ l RNase A at 10 mg ml −1 (Sigma) and 1 μ l rat anti-mouse CD71-FITC (Invitrogen RM5301) for 30 min on ice followed by 30 min at room temperature. 1 ml of 1.25 μ g ml −1 propidium iodide (Sigma) was added before data acquisition, using an LSR Fortessa (BD Biosciences). Data were analysed using FlowJo v.7.6.5 software (Tree Star). As the experiment was based on genotypes, no randomization was possible.
Assessment of immune responses. The concentration of CCL5 in supernatants was determined by ELISA (R&D Systems). The cellular response to dsDNA was determined using herring testes DNA (HT-DNA) (Sigma) at a final concentration of 1 μ g ml −1 (Extended Data Fig. 6 ) or interferon stimulatory DNA (ISD naked, InvivoGen) at a final concentration of 1.33 μ g ml −1 (Extended Data Fig. 8 ). Cells were incubated overnight and transfected the following day using Lipofectamine 2000/3000 in Opti-MEM reduced serum medium (both Thermo Fisher Scientific). The immune response was assessed at 24 h by ELISA using collected supernatant. Dose response to HT-DNA. C57BL/6J (Trp53 +/+ ) MEFs (5 × 10 4 per well) were seeded in a 12-well plate, incubated overnight and transfected the following day with HT-DNA at the specified concentrations (0-3,000 ng per well; Extended Data Fig. 7) using Lipofectamine 3000 in Opti-MEM reduced serum medium (Thermo Fisher Scientific). After 6 h the medium was replaced; supernatants were collected at 24 h and CCL5 concentrations assessed by ELISA. RT-qPCR. RNA was extracted from adherent cells using the RNeasy kit (Qiagen) per the manufacturer's instructions and using the included DNase I treatment. cDNA was prepared using Superscript III RT and random oligomer primers (Thermo Fisher Scientific). qRT-PCR was performed using SYBR Select Master Mix (Thermo Fisher Scientific) on an LC480 Real-Time PCR machine (Roche). The expression of target genes was normalized to the housekeeping gene Hprt using the formula (2− Δ C t ). Supplementary Table 1 shows the primers used. X-ray irradiation. 1.3 × 10 5 cells were seeded per well of a 6-well plate onto glass coverslips (Fig. 1 ). The following day, cells were irradiated for 1 min at a dose rate of 1 Gy per min using an X-ray irradiation system (Faxitron 43855D, Faxitron X-ray Corporation) operated at 130 kVp. After a further 48 h the culture medium was removed and CCL5 concentration assessed by ELISA (R&D systems). Cells on coverslips were fixed with 4% PFA in PBS for 20 min at room temperature for immunofluorescence imaging. Live cell imaging. For live cell imaging, Rnaseh2b −/− Trp53 −/− MEFs transiently expressing mCherry-H2B or U2OS cells stably expressing GFP-cGAS and mCherry-NLS were seeded onto glass-bottomed plates (Greiner Bio One). pmCherry-H2B (gift from P. Vagnarelli, Brunel University, London) was transfected by electroporation with the Neon transfection system (Thermo Fischer Scientific) according to the manufacturer's instructions. Prior to imaging, U2OS cells were treated with 200 ng ml −1 nocodazole (Sigma) for 12 h and additionally stained with 0.5 μ M SiR-DNA (Spirochrome). Cells were maintained at 37 °C in Leibovitz L-15 medium (Gibco). TRITC, FITC and Cy5 image datasets were collected using a 40× plan neofluor (0.75NA) objective on an Axiovert 200 fluorescence microscope (Zeiss) equipped with a Retiga6000 CCD camera (Qimaging) or an Axio-Observer Z1 fluorescence microscope (Zeiss) equipped with an Evolve EMCCD camera (Photometics). Images were recorded every 1.5 min over a 4-h period (U2OS cells) or every 5 min over a 16-h period (MEFs) using Micromanager (https://open-imaging.com/) and subsequently deconvolved using Volocity software (PerkinElmer). cGAS recruitment following micronuclear envelope disruption was analysed by measuring the mean fluorescence intensity of mCherry-NLS or GFP-cGAS over time. The mean fluorescence intensity for a cytoplasmic background of matched area was subtracted from the micronuclear signal. The background subtracted fluorescence intensity values were then normalized so that the highest fluorescence intensity was 1 and the lowest fluorescence intensity 0. The time of rupture (t = 0) was set at the point of maximal decline in the mean mCherry-NLS fluorescence signal. Rupture was observed in n = 40 micronuclei during live imaging experiments, in 29 of which detectable levels of cGAS were observed subsequently, and time of entry was then quantified in 11 of these, where movie length was sufficient to follow cGAS accumulation to maximal intensity. Serum starvation experiments. C57BL/6J (Trp53 +/+ ) MEFs (1.5 × 10 5 for asynchronous and 6 × 10 5 for serum starvation per well) were seeded into a 6-well plate (seeding densities were chosen to achieve similar cell numbers for both conditions at assay endpoint). After 5 h the medium was replaced with low-serum medium (0.25% FBS) for serum starvation, and with fresh medium (10% FBS) for asynchronous/cycling cells. After a further 24 h, the medium was again replaced with 1.6 ml (0.25% FBS for serum starved cells; 10% FBS for control cells), and cells irradiated with 1 or 5 Gy (at 1 Gy per min) (Faxitron 43855D, Faxitron X-ray Corporation). After 48 h the supernatants and cells were harvested, CCL5 measured by ELISA and RT-qPCR performed.
To assess the immune response of serum-starved cells to HT-DNA, C57BL/6J (Trp53 +/+ ) MEFs (1.5 × 10 5 per well) were seeded into a 6-well plate and grown in 10% or 0.25% FBS-containing medium for 24 h. Cells were then transfected with 1 μ g per ml HT-DNA in Opti-MEM using Lipofectamine 3000 (Thermo Fisher Scientific). After 6 h the medium was replaced with 10% or 0.25% FBS-containing medium, respectively, and 24 h after transfection supernatants were taken for ELISA. To ensure differences in cell number (arising from G0 arrest or irradiation) were not confounders for ELISA results, adherent cells were counted after trypsinization, with ELISA results corrected for final cell number per well.
To assess the frequency of micronuclei by immunofluorescence, cells were fixed with 4% PFA for 20 min at room temperature and permeabilized with 0.5% Triton X-100 for 5 min. Cover slips were mounted with Vectashield (with DAPI) and the percentage of cells with discrete micronuclei determined under blinded conditions. More than 500 cells per condition per experiment were analysed for micronucleus counts. To assess DNA damage by γ H2AX immunofluorescence in serum-starved and asynchronous cells after irradiation, 2 × 10 5 cells per well of a 6-well plate were seeded on coverslips and incubated in normal or 0.25% FBS medium. Cells were then irradiated with 1 or 5 Gy, and fixed 2 h later. n > 100 cells per condition per experiment (n = 2). Chromosome mis-segregation assay. Micronuclei induced by chromosome mis-segregation were generated pharmacologically by nocodazole treatment as described previously 7, 18 . MEFs were plated at 8 × 10 5 cells per 100-mm plate, and 24 h later incubated with 100 ng ml −1 nocodazole (Sigma) for 6 h. Mitotic cells were then harvested by shake-off and washed three times with PBS before counting and plating. 1 × 10 5 mitotic cells were plated per well of a 12-well plate into 800 μ l fresh medium. 1.5 × 10 4 mitotic cells were concurrently plated onto a coverslip in one well of a 12-well plate. After 48 h, culture medium was removed for ELISA and cells on coverslips fixed for imaging to determine micronucleus frequency.
To induce micronuclei in U2OS cells, 7 × 10 5 cells were seeded per 100-mm plate and incubated for 9 h. Cells were then synchronized with 2 mM thymidine (ACROS Organics) for 27 h and released by washing twice and replacing with fresh medium. After 14 h, U2OS cells were incubated with 100 ng ml −1 nocodazole (Sigma) for 6 h and mitotic cells harvested by shake-off. 3 × 10 4 mitotic cells were plated onto a coverslip in one well of a 12-well plate and incubated for 48 h before processing for microscopic analysis. Chromosome mis-segregation time-course assay. C57BL/6J Trp53 −/− MEFs (8 × 10 5 ) were plated in 10-cm plates. The next day, cells were incubated with 100 ng ml −1 nocodazole (Sigma) for 6 h and mitotic cells harvested using the shakeoff method. At this point supernatant was taken for the t = 0 time point. Mitotic cells were then plated into a 12-well plate (1 × 10 5 per well) or onto coverslips (7 × 10 4 ) for immunofluorescence analysis. Asynchronous cells were plated at the same number concurrently. Supernatants were taken and coverslips fixed after 6, 16 and 22 h. Immune response was analysed by ELISA and coverslips were preextracted on ice using 0.5% Triton X-100 in PBS for 5 min. Cells were then fixed with 4% PFA for 15 min at room temperature. After blocking for 30 min with 3% BSA at room temperature, γ H2AX Ser139 antibody (05-636 Millipore) was added for 2 h at room temperature. Alexa Fluor 568 goat anti-mouse secondary antibody (Life technologies) was then applied and incubated for 1 h at room temperature. Coverslips were mounted using Vectashield antifade mounting medium with DAPI (Vector laboratories) and imaged at room temperature using a Coolsnap HQ CCD camera (Photometrics) and a Zeiss Axioplan II fluorescence microscope with × 40 and × 63 plan-neofluor objectives and acquired using micromanager (http://open-imaging.com/). n ≥ 100 cells per condition (n = 1). siRNA knockdown. Cells were plated at an optimized density (2.5 × 10 5 U2OS cells per 6-cm dish) before overnight incubation and transfected the following day with siRNA oligonucleotides targeting cGAS (Dharmacon, M-015607-01-0005, siGENOME 115004) or luciferase (CUUACGCUGAGUACUUCGA, Sigma) at a final concentration of 25 nM. Transfections were performed using Oligofectamine (Thermo Fisher Scientific) per the manufacturer's instructions, in Opti-MEM reduced-serum medium (Thermo Fisher Scientific). Transfection medium was replaced with complete medium after 6 h and protein depletion confirmed 48 h post-transfection by immunoblotting. Immunoblotting. Whole-cell extracts were prepared by lysis and sonication of cells in UTB buffer (8 M urea, 50 mM Tris, pH 7.5, 150 mM β -mercaptoethanol, protease inhibitor cocktail (Roche)) and subsequently analysed by SDS-PAGE following standard procedures. In brief, protein samples (20 μ g) were resolved on a 4-12% NuPAGE Novex Bis-Tris mini gel (Thermo Fisher Scientific) and transferred onto a nitrocellulose membrane (GE Healthcare Life Sciences). The following antibodies were used for immunoblotting: cGAS (D1D3G, Cell Signalling, 1:1,000) and actin (A2066, Sigma, 1:5,000). cGAS purification. The coding sequence of the enzymatically active portion of human cGAS (amino acids 157-522) was cloned into pGEX6P1 and protein expressed overnight at 18 °C by induction with 0.3 mM IPTG in Rosetta-2 cells. Cells were lysed by sonication in 25 mM Tris-HCl pH 8, 1 M NaCl, 10% glycerol, 0.5% IGEPAL CA-630, 1 mM DTT. GST-cGAS was affinity purified using glutathione sepharose 4B (GE Healthcare Life Sciences) and cGAS released by PreScission Protease cleavage in 50 mM Tris-HCl pH 7.5, 0.5 M NaCl, 1 mM MgCl 2 , 1 mM DTT. In vitro assay for cGAS activity. The cGAS enzyme activity assay was performed as described 11 with minor modifications. Reactions were carried out at 37 °C in 10 μ l with 2 μ M recombinant cGAS (amino acids 157-522), 100 ng DNA (or equivalent chromatin), 1 mM GTP and 10 μ Ci [α -32P]-ATP in 13.75 mM Tris-HCl pH 7.5, 37.5 mM NaCl, 4 mM MgCl 2 . Reactions were stopped by the addition of EDTA. To separate ATP and cGAMP, TLC was performed on 10 × 10-cm HPTLC Silica gel 60 F254 glass plates (Merck Millipore). Samples were spotted onto the plates and separation was performed in n-propanol/ammonium hydroxide/water (11:7:2 v/v/v). The plate was air-dried and images collected using phosphorimaging screens and the FLA-5100 imaging system (Fujifilm). Chromatin synthesis and purification. Soluble chromatin was prepared from NIH3T3 cells as previously described 38, 39 but an increased concentration of NP40 detergent (0.2%) was used in buffer NBB and buffer NBR was replaced by buffer NBR2 (buffer NBR modified to contain 1 mM MgCl 2 and 1 mM CaCl 2 ). Nuclei were resuspended at 20 A260 in buffer NBR2 and digested with MNase (400 units per ml nuclei; NEB) for 10 min at room temperature. The reaction was stopped by adding EDTA to 10 mM, and nuclei were resuspended in 500 μ l TEP20N (10 mM Tris, pH 8; 1 mM EDTA; 20 mM NaCl, 0.5 μ M PMSF, 0.05% NP40) and incubated at 4 °C overnight. Soluble chromatin was recovered by centrifugation (5 min, 20,000g) and purified on a 10-50% step gradient in TEP80 (10 mM Tris, pH 8; 1 mM EDTA; 80 mM NaCl, 0.5 μ M PMSF) in a SW55 centrifuge tube (Beckman) and centrifuged at 50,000 r.p.m. for 105 min in a SW55 rotor as described 40 . Chromatin was recovered by upward displacement while monitoring the absorbance at 254 nm in 10 samples of 0.5 ml. Aliquots of each fraction were analysed for DNA and protein to check sample integrity. Peak chromatin fractions were dialysed into TEP80 overnight and the concentration determined by measuring the absorbance at 260 nm in 2 M NaCl, 5 M Urea. Naked DNA was prepared from chromatin by proteinase K treatment in 0.25% SDS, 50 mM NaCl, 5 mM EDTA for 2 h at 55 °C, followed by phenol/chloroform extraction and ethanol precipitation.
Synthetic chromatin was prepared using standard approaches adapted from refs 41, 42. Essentially, a 601 DNA template (25 × 197 bp 601 DNA) was reconstituted with purified chicken core histone octamers at a 1:1 molar ratio in TEP2000 (10 mM Tris, pH 7.5, and 0.2 mM EDTA, 2 M NaCl, 0.5 μ M PMSF) and dialysed from 2 M to 400 mM over 6 h and then into 10 mM NaCl overnight, using a Thermofisher microdialysis cap (10,000 MWCO) in a linear gradient maker. Chromatin concentration was measured by measuring absorbance at 254 nm and reconstitution chromatin was analysed by band-shifts, sucrose gradient sedimentation and nuclease digestion. Single-cell laser capture microdissection. C57Bl/6J MEFs were irradiated (1 Gy) and re-seeded onto 50 mm PEN membrane dishes (Zeiss) 32 h later. Picogreencontaining medium (Quant-iT PicoGreen dsDNA reagent, 4 μ l per ml) was added to the cells 48 h after irradiation to stain DNA, and laser capture microdissection (LCM) performed as follows. Micronucleated cells (n = 32) and control cells with normal nuclear morphology (n = 28) were identified from the same dish using a GFP filter, and LCM of individual cells performed using a Zeiss Palm Microbeam 4 Microscope. Cells were collected into 5 μ l 0.2% (v/v) Triton X-100, 2 U μ l −1 RNasin Ribonuclease Inhibitor (Promega), snap frozen on dry ice and stored at − 80 °C until library preparation cDNA and library preparation. All 60 cells obtained from LCM were processed in two batches (until cDNA amplification), with approximately equal numbers of MN+ and MN− cells in each batch, and cDNA from single cells was obtained using the Smart-seq2 protocol 43 with minor modifications, as described previously 44 . Cells from each batch were processed in LCM-compatible 0.5 ml Eppendorf tubes until cDNA amplification and both batches then transferred to a single 96-well plates for library generation using Illumina Nextera reagents. Libraries were assessed for size distribution on an Agilent Bioanalyser (Agilent Technologies) with the DNA HS Kit, and then quantified using a Qubit 2.0 Fluorometer (Thermo Fisher Scientific) and the Qubit dsDNA HS Assay Kit. Finally, parallel paired end sequencing (2 × 75 bp) was performed using the NextSeq 500/550 Mid-Output v2 (150 cycle) Kit on the NextSeq 550 platform (Illumina). Single-cell RNA sequencing data analysis. Reads were mapped against the Ensembl mouse reference genome version GRCm38.p5 with the inclusion of the reference for the spike in controls from the ERCC consortium 45 using a STAR RNA-seq aligner 46 . For quality control and pre-processing, quantification of mapped reads per gene was calculated using Rsubread 47 . Genes with no expression detected in all cells were excluded. The gene counts were loaded into the R package scater and standard quality control metrics were calculated 48 . Quality control exclusion criteria were cells with more than 10% of reads mapping to ERCCs or fewer than 40,000 reads or fewer than 2,000 genes detected (at least one read per gene). For the GSEA analysis, genes were ranked from MN+ to MN− using a z-score calculated with the SCDE R package 49 . The ranked gene list was loaded into GSEA and tested against a list of 336 genes shown to be induced in MEFs in response to type I IFN 50 . For direct comparisons of genes between MN+ and MN− cells in the heatmap and browser shots, mapped reads were imported into SeqMonk (https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/)
Letter reSeArCH and down-sampled to the same number of reads for every cell. Raw reads were counted over genes and genes with at least one read were scored as detected genes. Heatmaps were generated using Matrix2png 51 . The upper part of the heatmap (Fig. 5b) shows detected ISGs, from a high confidence list of genome instability induced ISGs, calculated as the overlap between genes identified in refs 52 and 5. Out of these 11 genes, transcripts for 5 were not detected in any cell. A Fisher's exact test was performed under the null hypothesis that there was no excess of transcribed ISGs in MN+ versus MN− cells. Genome browser shots were taken from pooled reads from all MN+ and MN− cells after pools were down-sampled to the same number of reads. Statistics. All data are plotted as mean values, with variance as s.e.m. unless stated otherwise. Statistical analysis was performed using Prism (Graphpad Software Inc.). For all quantitative measurements, normal distribution was assumed, with t-tests performed, unpaired and two-sided unless otherwise stated. No statistical methods were used to predetermine sample sizes, which were determined empirically from previous experimental experience with similar assays, and/or from sizes generally employed in the field. Data availability. Single-cell RNA sequencing data that support the findings of this study have been deposited in GEO with the accession code GSE100771. All other data are available upon reasonable request from the corresponding authors. g, Increased levels of ISG transcripts (Ifit1, Ifit3, Isg15, Cxcl10 and Oas1a) were detected in C57BL/6J (Trp53 +/+ ) MEFs 48 h after irradiation. Transcript levels were normalized to Hprt. Mean ± s.e.m., n = 3 independent experiments. One-way ANOVA, 2 degrees of freedom, * P < 0.05. h, Endogenous cytosolic cGAS accumulates in micronuclei in U2OS cells. Representative images of cGAS distribution in cells with or without micronuclei. Images taken using different exposure times (200 vs 700 ms) to visualize weaker cytosolic cGAS signal. i, j, Verification of anti-cGAS antibody specificity in human cells. i, The percentage of cGAS-positive micronuclei, using anti-cGAS immunofluorescence, was determined microscopically after cGAS or luciferase siRNA knockdown. Mean ± s.e.m., n = 2 experiments (500 cells counted per experiment); two-tailed t-test. While several commercial cGAS antibodies were assessed, specific detection of mouse cGAS by immunofluorescence was not possible with these reagents (data not shown). j, Immunoblot after siRNA knockdown of cGAS in U2OS cells. siRNA targeting luciferase (siLUC) was used as a negative control. Probing with anti-actin antibody shows equal loading. Fig. 1h ). c, CCL5 response of wild-type C57/BL6 MEFs to ionizing radiation plotted in pg per 10 5 cells. Reanalysis of this dataset (first depicted in Fig. 4b ) confirms that the prior statistical analysis is robust to data normalization on the basis of cell counts at assay endpoint. 1 Gy of irradiation in cycling MEFs results in 38 ± 5 pg (mean ± s.d.) of CCL5 per 10 5 cells. * * P < 0.01, two-tailed t-test; NS, not significant. d, Dose-response curve of secreted CCL5 in wild-type C57BL/6 (Trp53 +/+ ) MEFs transfected with serial dilutions of transfected HT-DNA.
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Therefore, around 4 ng of transfected DNA resulted in a similar level of cytokine production to c. Mean and 95% confidence interval indicated by black and grey dashed lines, respectively. Given the similarity of the two estimates, within the same order of magnitude, micronuclear DNA is likely to be sufficient to account for the immune response observed. Conversely, ionizing radiation would not be expected to generate this quantity of small DNA fragments as 1 Gy irradiation generates ~ 40 double strand breaks (DSBs) 54 , and ~ 1,000 base lesions and single-stranded breaks. DSBs will have an average separation of 150 Mbp, and will therefore be too widely spaced to directly generate small dsDNA fragments. Repair of DNA lesions can generate small single-stranded DNA (ssDNA) fragments through endonuclease activity. The best characterized fragments are those generated by nucleotide excision repair, where endonucleolytic cleavage yields 24-32-nucleotide ssDNA fragments 55 . As such these are not an ideal substrate for cGAS activation, and 5 million such lesions per cell would have to be generated to produce 4 ng of cytosolic DNA in 10 5 cells. Hence, on the basis of our understanding of the current literature, such DNA fragments are likely to be generated at a level that is orders of magnitude lower than that of micronuclear DNA after radiation-induced damage.
Extended Data Figure 9 | Single-cell RNA sequencing quality control and microscopy images of individual LCM-captured cells. a, Total gene feature counts (reads mapping to a protein coding gene) vs ERCC (RNA spike-in) percentage of total counts per cell. Cells with ERCC percentage counts > 10% and/or with feature counts < 2,000 were rejected, indicated by red shaded regions. b, Summary statistics for 21 micronucleated (MN+ ) cells and 14 non-micronucleated (MN− ) cells that passed quality control. c, d, Microcopy images of cells captured by LCM that passed quality control after single-cell RNA sequencing. Fourteen live cells without micronuclei (c) and 21 live cells with micronuclei (d) were isolated from the same culture dish using LCM and used for single-cell mRNA sequencing. DNA was stained with picogreen dsDNA stain. Cells shown are those that passed quality control; numbers indicate the order in which cells were captured. Scale bars, 10 μ m. Corresponding author(s): A. P. Jackson
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Experimental design 1. Sample size
Describe how sample size was determined. Sample sizes used throughout were consistent with those used in previous studies.
Data exclusions
Describe any data exclusions. No exclusion of data was made.
Replication
Describe whether the experimental findings were reliably reproduced.
Experimental findings were reliably reproduced. Number (n) of biological and experimental replicates is stated in the figure legends. All attempts at replication were successful for the experiments described in the manuscript.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice/cell lines were allocated into groups according to genotype of interest.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were blinded during data collection and analysis where possible. This included FACS data collection, enumeration of micronuclei numbers, and single RNAseq analysis upto the point of grouped analyses.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
